We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.

Settings

Save and close

JAX Frontend Platform

Antibody Drug Discovery

Antibody therapeutics have revolutionized modern medicine, offering highly specific and effective treatments for a wide range of diseases. At The Jackson Laboratory, we provide cutting-edge transgenic mouse models, including the Atlas™ platform, to accelerate monoclonal, bispecific, and multispecific antibody discovery.

Speak to an Expert

Antibody Drug Discovery at The Jackson Laboratory

Atlas™ Full Human Diversity Mouse for Monoclonal Antibody Discovery

Thoughtfully designed to overcome many of the challenges with legacy technologies.

  • Engineered knock-in of full diversity, human variable heavy and kappa light chains into endogenous mouse loci
  • Selected variable regions comprise >99% of commonly expressed human sequences
  • Incorporates only functional heavy and kappa light chain domains to promote optimal B-cell rearrangement

Learn More about Full Human Diversity

Atlas™ Full Human Diversity vs. WT Mice Day 35 Serum Titers

Atlas™ Full Human Diversity vs. WT Mice EC50 Comparison Soluble CD22

Atlas™ Binary Fixed Light Chain Mouse for Bispecific and Multispecific Antibody Discovery

Designed to enable the creation of bispecific and multispecific therapies that mimic native antibody structures.

  • Generates antibodies allowing pairing of heavy and light chains without linkers, fusions, or modifications
  • Supports target-driven selection from one of two fixed light chains in the context of a full diversity heavy chain
  • Allows for improved diversity and hit recovery through optionality of two fixed kappa light chain pairings

Learn More about Binary Fixed Light Chain

Atlas™ Binary Fixed Light Chain Mice vs. WT Mice Day 35 Serum Titers

Atlas™ Binary Fixed Light Chain Mice vs. WT Mice EC50 Comparison Soluble CD22

The Jackson Laboratory and AbTherx

Our partnership with AbTherx combines decades of expertise in transgenic model development with advanced antibody discovery technologies, helping researchers generate antibodies with the diversity, affinity, and developability needed for successful therapeutic applications. Explore our innovative solutions to streamline drug discovery and bring life-saving treatments to patients faster.

The Jackson Laboratory & AbTherx

Discover More

Watch "Atlas™ Mice Provide a New and Differentiated Toolset for Rapid Generation of Developable Human Therapeutic Antibodies"

Listen to Dan Rohrer from AbTherx talk about the Atlas™ Mouse platform and its role in the discovery of life saving medicines.

Watch the Webinar

JAX Resources - Watch Atlas™ Mice Provide a New and Differentiated Toolset for Rapid Generation of Developable Human Therapeutic Antibodies

View our Atlas™ Mouse Tech Sheet for more Data

With a near-complete repertoire of human antibody gene diversity, these mice enable in vivo selection and maturation, reducing the need for extensive downstream engineering and accelerating development.

View the Tech Sheet to Learn More

Not what you're looking for?
Visit our Resource Hub

JAX Resources - View our Atlas™ Mouse Tech Sheet for more Data
Sign Up | JAX Pulse Stay informed about our events, blogs and videos, and cutting-edge research platforms.
Get Updates Right in Your Inbox

©2025 The Jackson Laboratory